Ushikulide C (1), a new immunosuppressant, was isolated from the culture broth of Streptomyces sp. IUK-102. The structure of 1 is a new 22-membered macrolide that is related to ushikulides A (2) and B (3). The immunosuppressive activity of 1 on murine splenocyte proliferation in vitro was comparable with those of 2 and 3.
Cyclosporin
A and FK506, both extremely potent immunosuppressive drugs, have been immensely useful in organ transplantation because of their ability to block the activation of lymphocytes and prevent rejection [1, 2] . The elucidation of the mechanism behind their immunosuppressive activity has promoted a better understanding of the immune system [3] . Cyclosporin A and FK506 bind to cyclophilin and the FK506-binding protein (FKBP or immunophilin), respectively [3] . The binding of each of these drug-protein complexes to a catalytic subunit of calcineurin results in signal transduction inhibition in T cell activation [3] . During our screening for immunosuppressants from the culture broth of microorganisms, we identified ushikulides A (2) and B (3) in the culture broth of Streptomyces sp. IUK-102 [4] . Trost et al. achieved a stereoselective total synthesis of 2, and the absolute structure was determined as shown in Figure 1 [5, 6] . Further research into new immunosuppressants from Streptomyces sp. IUK-102 revealed ushikulide C (1). The isolation, structure elucidation, and biological activity of 1 are described in this report.
The Streptomyces sp. IUK-102 fermentation conditions have been previously reported [4] . Fourteen liters of the culture broth was centrifuged to separate the mycelia and the supernatant. The supernatant was extracted with ethyl acetate. The mycelia were soaked in acetone, and the extract evaporated to give an aqueous residue. This was then extracted twice with ethyl acetate. Both ethyl acetate extracts were combined and evaporated to yield a dark brown residue (7.5 g), which was subjected to SiO 2 gel chromatography (250 g), eluting with chloroform (2 L), followed by a mixture of chloroform and methanol (9:1, 2 L). The fractions with biological activity were concentrated in vacuo and fractionated on a SiO 2 gel column (100 g) using a mixture of chloroform and methanol (95:5, 1 L). The bioactive fractions were combined and concentrated in vacuo. This bioactive material was then loaded onto a reverse-phase HPLC column (CAPCELL PAK C18 UG 80,10 mm x 250 mm, Shiseido Co. Ltd., Japan) using 70% aqueous acetonitrile solution as an isocratic mobile phase at a flow rate of 3.0 mL/min to yield 1 (3 mg). . The IR spectrum showed the presence of hydroxyl and carbonyl groups at 3395 and 1700 cm -1 , respectively. The 1 H NMR, 13 C NMR, and edited HSQC spectral data of 1 showed the presence of an ester carbonyl, 4 sp 2 methines, 2 sp 3 quaternary carbons, 14 sp 3 methines (including 8 oxymethines), 12 sp 3 methylenes, and 7 methyl carbons. Six degrees of unsaturation were inferred from the molecular formula. The comparison of the NMR data from 1 with those of 2 suggested that one oxymethine and one oxymethylene were present, but a methyl and a carbonyl were lost in the structure of 1 [4] . The coupling constant values for the four proton signals corresponding to the double bond protons were approximately 15 Hz. The geometry of the two double bonds in the structure of 1 was found to have an E-configuration. Due to the presence of two double bonds and an ester carbonyl, three ring structures were found in 1. The spectral data from 1 were similar to those of 2 and 3 [4] . The COSY and HSQC-TOCSY spectra of 1 revealed three 1 H-1 H spin coupling systems: I, II, and III (Figure 2A ). The HMBC correlations from H-2 ( 5.81) and H-21 ( 5.26) to C-1 ( 166.9) showed an ester bond between C-1 and C-21. The connectivities between C-9, C-10, C-11, and C-34 were revealed by HMBC correlations from H 3 -34 ( 1.03) to C-9 (75.4), C-10 ( 75.6), and C-11 (38.6) and from H 2 -11 (1.68/1.30) to C-10. These data revealed the linkage of 1 H-1 H spin coupling systems I and II; therefore, the basic structure of 1 was found to be a 22-membered lactone (Figure 2A ). ( 1.28/ 1.69) to C-23 ( 98.7) (Figure 2A) . Given the degree of unsaturation and the chemical shift of C-23, it was speculated that an acetal carbon in a spiroketal moiety was present. However, the linkage from C-19 and C-27 to C-23 via oxygen atoms was not confirmed by HMBC spectral data. ( Figure 2B ). As a result, correlations between H-27 and C-19 and between H-19 and C-27 were found in the spectrum of the phasesensitive HSQC-ROESY ( Figure 2B ). This spectrum showed spatial proximity between C-19 and C-27 and the presence of 1,1'dioxaspiro [5.5] undecane fused to the 22-membered lactone ( Figure  2A ). Finally, the structure of 1 was determined and is shown in Figure 1 . All of the assigned proton and carbon signals are listed in Table 1 . Because ushikulides A (2), B (3), and C (1) were produced by the same actinomycetes, it is probable that these compounds are synthesized by the same biosynthetic pathway; therefore, the stereochemistries of these compounds should be identical. The process to determine the stereochemistries of 1 and 3 is ongoing.
The immunosuppressive activity of 1 was investigated by concanavalin A (ConA)-stimulated murine lymphocyte blastogenesis according to the method of Kurosawa et al. [7] . Ushikulide C inhibited murine splenic lymphocyte proliferation with an IC 50 value of 72 nM, comparable with those of cyclosporin A, ushikulides A and B [4] . Furthermore, ushikulide C did not display significant cytotoxicity in KB cells until 10 M was reached.
Experimental
Instruments: IR spectra were measured using a Jasco FT/IR 4100 infrared spectrometer (Tokyo, Japan). Mass spectra were obtained on a Jeol JMS-SX102A mass spectrometer (Tokyo, Japan). Optical rotation values were measured with a Jasco P-2200 digital polarimeter (Tokyo, Japan). NMR spectra were recorded on a Brucker AMX-500 FT-NMR spectrometer (Karlsruhe, Germany).
